Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceutical Partners, Inc.    CPRX   US14888U1016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
4.33(c) 4.27(c) 4.13(c) 3.91(c) 4.19(c) Last
1 448 915 1 066 584 1 144 607 770 554 534 459 Volume
-8.65% -1.39% -3.28% -5.33% +7.16% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -32,4 M
Net income 2015 -32,3 M
Debt 2015 -
Yield 2015 -
Sales 2016 14,0 M
EBIT 2016 -21,2 M
Net income 2016 -21,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 24,4x
Capitalization 341 M
More Financials
Company
Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and... 
More about the company
Surperformance© ratings of Catalyst Pharmaceutical Pa
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICAL PA
03/27 CATALYST PHARMACEUTICAL PARTNERS : Entry into a Material Definitive Agreement, F..
03/17 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Fourth Quarter and ..
03/16 CATALYST PHARMACEUTICAL PARTNERS : reports 4Q loss
03/16 Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial..
03/09 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Present at the 27th Annual..
03/09 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Present at the 27th Annual..
03/05 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces FDA Orphan Drug Des..
03/04 CATALYST PHARMACEUTICAL PARTNERS : Brookhaven Science Associates, Northwestern U..
More news
Sector news : Bio Therapeutic Drugs
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/16 Catalyst Pharma Q4 and FY14 results
03/16 Catalyst Pharmaceutical beats by $0.01
03/05 Catalyst Pharma's Firdapse an Orphan Drug for inherited muscle weakness disor..
02/04 Catalyst prices equity offering
02/04 PREMARKET GAINERS / LOSERS AS IF 9 : 10 am


Comments 
Advertisement
Chart CATALYST PHARMACEUTICAL PA
Duration : Period :
Catalyst Pharmaceutical Pa Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF